These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 20217945

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Is non-prescription oseltamivir availability under strict criteria workable? A qualitative study in New Zealand.
    Gauld N, Kelly F, Shaw J.
    J Antimicrob Chemother; 2011 Jan; 66(1):201-4. PubMed ID: 21051373
    [Abstract] [Full Text] [Related]

  • 23. Quality of global e-pharmacies: can we safeguard consumers?
    Bessell TL, Silagy CA, Anderson JN, Hiller JE, Sansom LN.
    Eur J Clin Pharmacol; 2002 Dec; 58(9):567-72. PubMed ID: 12483449
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Reporting natural health product related adverse drug reactions: is it the pharmacist's responsibility?
    Walji R, Boon H, Barnes J, Welsh S, Austin Z, Baker GR.
    Int J Pharm Pract; 2011 Dec; 19(6):383-91. PubMed ID: 22060233
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Over-the-counter prescribing and pharmacists' adoption of new medicines: diffusion of innovations.
    Paudyal V, Hansford D, Cunningham S, Stewart D.
    Res Social Adm Pharm; 2013 Dec; 9(3):251-62. PubMed ID: 22835710
    [Abstract] [Full Text] [Related]

  • 32. Barriers to positive policy change that aims to increase access to medicines through reclassification: the case of oseltamivir in New Zealand.
    Shaw JP, Gauld N, Kelly F.
    Int J Pharm Pract; 2016 Feb; 24(1):6-12. PubMed ID: 26154432
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL, Kelly F, Fowler J, Wheeler AJ.
    Res Social Adm Pharm; 2017 Feb; 13(5):969-979. PubMed ID: 28583302
    [Abstract] [Full Text] [Related]

  • 37. Management of drug-interaction alerts in community pharmacies.
    Indermitte J, Beutler M, Bruppacher R, Meier CR, Hersberger KE.
    J Clin Pharm Ther; 2007 Apr; 32(2):133-42. PubMed ID: 17381663
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. What affects asthma medicine use in children? Australian asthma educator perspectives.
    Chong JJ, Davidsson A, Moles R, Saini B.
    J Asthma; 2009 Jun; 46(5):437-44. PubMed ID: 19544161
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.